Wealthstar Advisors LLC reduced its holdings in shares of iShares Core S&P 500 ETF (NYSEARCA:IVV – Free Report) by 4.2% during the 1st quarter, Holdings Channel.com reports. The fund owned 1,476 shares of the company’s stock after selling 65 shares during the period. Wealthstar Advisors LLC’s holdings in iShares Core S&P 500 ETF were worth […]
Soltis Investment Advisors LLC Sells 1,283 Shares of iShares Core S&P 500 ETF (NYSEARCA:IVV) kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Achmea Investment Management B.V. increased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 9.8% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 116,766 shares of the healthcare product maker’s stock after buying an additional 10,398 shares during the period. Achmea Investment […]
Axxcess Wealth Management LLC grew its position in Abbott Laboratories (NYSE:ABT – Free Report) by 0.1% during the 1st quarter, HoldingsChannel.com reports. The firm owned 67,081 shares of the healthcare product maker’s stock after acquiring an additional 98 shares during the quarter. Axxcess Wealth Management LLC’s holdings in Abbott Laboratories were worth $6,793,000 as of […]
Abbott Laboratories (NYSE:ABT – Free Report) had its price target lifted by Barclays from $127.00 to $132.00 in a report issued on Monday, MarketBeat reports. Barclays currently has an overweight rating on the healthcare product maker’s stock. Several other analysts have also recently weighed in on ABT. Raymond James lifted their price objective on Abbott […]